List of Studies ( Metabolite:SM 18:0;O2/16:0)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004035 | AN006673 | Serum Metabolites at Defined Stages of Liver Disease | Liver | Mouse | Liver disease | University of Texas Health Science Center at Houston | LC-MS |
| ST004002 | AN006601 | A deep, quantitative lipid atlas of extracellular vesicles across multiple cell lines | Extracellular vescicles | Human | Cancer | European Molecular Biology Laboratory | LC-MS |
| ST004002 | AN006601 | A deep, quantitative lipid atlas of extracellular vesicles across multiple cell lines | Extracellular vescicles | Mouse | Cancer | European Molecular Biology Laboratory | LC-MS |
| ST003927 | AN006450 | Histidine decarboxylase inhibition attenuates cancer-associated muscle wasting | Muscle | Mouse | Cancer | Indiana University School of Medicine | LC-MS |
| ST003917 | AN006431 | Gut Microbial Bile and Amino Acid Metabolism Associate with Peanut Oral Immunotherapy Failure | Feces | Human | Allergy | University of California, San Francisco | LC-MS |
| ST003798 | AN006243 | Metabolic signature in combination with fecal immunochemical test as a non-invasive tool for advanced colorectal neoplasia diagnosis | Feces | Human | Cancer | CICbiogUNE | LC-MS |
| ST003751 | AN006158 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Blood | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006158 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Urine | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006159 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Blood | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003751 | AN006159 | Comprehensive Lipidomic Analysis Identifies Critical Lipid and Metabolic Pathway Shifts in Alport Syndrome | Urine | Human | Kidney disease | Universidad CEU San Pablo | LC-MS |
| ST003694 | AN006061 | FOLFIRINOX effects on lipidomics in pancreatic cancer cells | Pancreas | Human | Cancer | Pennsylvania State University | LC-MS |
| ST003673 | AN006032 | Identification of plasma metabolites responding to oxycodone exposure in rats | Blood | Rat | Addiction | University of Colorado Anschutz Medical Campus | Other |
| ST003672 | AN006029 | Advanced Lipidomics Using UHPLC-ESI-QTOF-MS/MS Reveals Novel Lipids in Hibernating Syrian Hamsters | Brain | Golden hamster | Universidad CEU San Pablo | LC-MS | |
| ST003637 | AN005973 | lomitapide effects on lipidomics | Pancreas | Human | Cancer | Pennsylvania State University | LC-MS |
| ST003580 | AN005880 | Metabolomic profiling of normal and fibrotic mouse lungs | Lung | Mouse | Lung disease | University of Alabama, Birmingham | LC-MS |
| ST003575 | AN005870 | Lipidomic Profiling of a Preclinical Model of Streptozotocin induced Diabetic Cardiomyopathy | Blood | Mouse | Cardiovascular disease | Baker Heart and Diabetes Institute | LC-MS |
| ST003546 | AN005826 | Improved Soil Health and Pasture Phytochemical Richness Underlies Improved Beef Nutrient Density in Southern US Grass-Finished Beef Systems | Muscle | Cow | Utah State University | Other | |
| ST003520 | AN005779 | Identification of Plasma Metabolomic Biomarkers of Juvenile Idiopathic Arthritis | Blood | Human | Arthritis | University of Kansas | LC-MS |
| ST003514 | AN005769 | Highly reliable LC-MS lipidomics database for efficient human plasma profiling based on NIST SRM 1950 | Blood | Human | Universidad CEU San Pablo | LC-MS | |
| ST003472 | AN005707 | An Optimized Plasmalogen Dietary Supplement Remodels the Cardiac Lipidome and Proteome, Providing Greater Protection in a Male Mouse Model of Dilated Cardiomyopathy Over Females | Blood | Mouse | Heart disease | Baker Heart and Diabetes Institute | LC-MS |
| ST003472 | AN005707 | An Optimized Plasmalogen Dietary Supplement Remodels the Cardiac Lipidome and Proteome, Providing Greater Protection in a Male Mouse Model of Dilated Cardiomyopathy Over Females | Heart | Mouse | Heart disease | Baker Heart and Diabetes Institute | LC-MS |
| ST003398 | AN005577 | Specific activation of the integrated stress response (ISR) uncovers regulation of lipid droplet biogenesis | Cultured cells | Human | Cancer | Calico Life Sciences | LC-MS |
| ST003326 | AN005448 | Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism | Liver | Mouse | Liver disease | University of Melbourne | LC-MS |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | Blood | Mouse | Brown University | Other | |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | Cecum | Mouse | Brown University | Other | |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | Colon | Mouse | Brown University | Other | |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | DSI | Mouse | Brown University | Other | |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | Liver | Mouse | Brown University | Other | |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | MSI | Mouse | Brown University | Other | |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | PSI | Mouse | Brown University | Other | |
| ST003277 | AN005366 | LC-MS/MS spatial analysis of mouse GI | Stomach | Mouse | Brown University | Other | |
| ST003222 | AN005283 | A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 | Heart | Mouse | Ischemia | University of Mississippi Medical Center | LC-MS |
| ST003220 | AN005280 | Obesity, sex, and depot drive distinct lipid profiles in murine white adipose tissue | Adipose tissue | Mouse | Obesity | University of Utah | LC-MS |
| ST003178 | AN005218 | Post-Infectious MECFS at the NIH | Cerebrospinal fluid | Human | Chronic fatigue syndrome | National Institutes of Health | Other |
| ST003132 | AN005140 | Untargeted Metabolomics on Mouse colonic mucosa | Colonic mucosa | Mouse | University College Cork | Other | |
| ST003131 | AN005136 | Untargeted Metabolomics on mouse caecal contents | Cecum | Mouse | University College Cork | Other | |
| ST003130 | AN005134 | Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Maternal blood | Blood | Mouse | University of Copenhagen | LC-MS | |
| ST003129 | AN005132 | Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Maternal liver | Liver | Mouse | University of Copenhagen | LC-MS | |
| ST003125 | AN005124 | Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Fetal liver | Liver | Mouse | Maternal immune system activation | University of Copenhagen | LC-MS |
| ST003103 | AN005077 | Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach | Blood | Human | COVID-19 | Universidad CEU San Pablo | GC-MS/LC-MS |
| ST002978 | AN004892 | Metabolite Profiling Of Vaginal Microbes In Suspension And Biofilm Cultures: Potential Target Against Bacterial Vaginosis | Bacterial cells | Gardenerella vaginalis | Bacterial Vaginosis | Purdue University | Other |
| ST002978 | AN004892 | Metabolite Profiling Of Vaginal Microbes In Suspension And Biofilm Cultures: Potential Target Against Bacterial Vaginosis | Bacterial cells | Lactobacillus crispatus | Bacterial Vaginosis | Purdue University | Other |
| ST002978 | AN004892 | Metabolite Profiling Of Vaginal Microbes In Suspension And Biofilm Cultures: Potential Target Against Bacterial Vaginosis | Bacterial cells | Lactobacillus iners | Bacterial Vaginosis | Purdue University | Other |
| ST002967 | AN004875 | Lipidomics study of FASN inhibition in HT-29 and HCT 116 spheroids | Cultured cells | Human | Cancer | Ohio State University | LC-MS |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Blood | Mouse | University of Kansas | LC-MS | |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Brain | Mouse | University of Kansas | LC-MS | |
| ST002958 | AN004858 | Lipidomic analysis of demyelination and remyelination in the Plp1-iCKO-Myrf mouse model of demyelination | Spinal cord | Mouse | University of Kansas | LC-MS | |
| ST002956 | AN004853 | An application of automated LLE extraction in determine the age and HFD effects in adult mice in metabolomic, lipidomic, and proteomic | Blood | Mouse | Calico Life Sciences | LC-MS | |
| ST002939 | AN004824 | Role of PI3K in Atrial Myopathy: Insights from Transgenic Mouse Models and Identification of a Dysregulated PI3K Lipid Profile in Individuals with Atrial Fibrillation - Part 2 of 2, Mus musculus | Atria | Mouse | Atrial fibrillation | Baker Heart and Diabetes Institute | LC-MS |
| ST002939 | AN004824 | Role of PI3K in Atrial Myopathy: Insights from Transgenic Mouse Models and Identification of a Dysregulated PI3K Lipid Profile in Individuals with Atrial Fibrillation - Part 2 of 2, Mus musculus | Ventricles | Mouse | Atrial fibrillation | Baker Heart and Diabetes Institute | LC-MS |
| ST002938 | AN004823 | Role of PI3K in Atrial Myopathy: Insights from Transgenic Mouse Models and Identification of a Dysregulated PI3K Lipid Profile in Individuals with Atrial Fibrillation - part 1 of 2, human plasma | Blood | Human | Atrial fibrillation | Baker Heart and Diabetes Institute | LC-MS |
| ST002911 | AN004780 | LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation | Lung | Mouse | Tuberculosis | Universidad CEU San Pablo | LC-MS |
| ST002911 | AN004781 | LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation | Lung | Mouse | Tuberculosis | Universidad CEU San Pablo | LC-MS |
| ST002909 | AN004776 | Plasma metabolomics reveals distinct biological and diagnostic signatures for melioidosis | Blood | Human | Melioidosis | University of Washington | Other |
| ST002837 | AN004638 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Blood) | Blood | Mouse | Anxiety | National Center for Advancing Translational Sciences | Other |
| ST002836 | AN004634 | Bacterial tryptophan metabolites increased by prebiotic galactooligosaccharide reduce microglial reactivity and are associated with lower anxiety-like behavior (Intestine) | Intestine | Mouse | Anxiety | National Center for Advancing Translational Sciences | Other |
| ST002829 | AN004620 | Nucleotide, phospholipid, and kynurenine metabolites are robustly associated with COVID-19 severity and time of plasma sample collection in a prospective cohort study | Blood | Human | COVID-19 | National Institutes of Health | Other |
| ST002822 | AN004600 | Effect of ERR Agonist in Mouse Heart Post Pressure Overload | Heart | Mouse | Baylor College of Medicine | Other | |
| ST002820 | AN004595 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (AASKG1) | Blood | Human | Tufts Medical Center | Other | |
| ST002819 | AN004591 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (MDRD) | Blood | Human | Tufts Medical Center | Other | |
| ST002818 | AN004587 | Evaluation of Novel Candidate Filtration Markers from a Global Metabolomics Discovery for Glomerular Filtration Rate Estimation (ALTOLD) | Blood | Human | Tufts Medical Center | Other | |
| ST002809 | AN004567 | Role of cilia in mitochondrial function | Cultured cells | Dog | Kidney disease | Medical University of South Carolina | LC-MS |
| ST002809 | AN004567 | Role of cilia in mitochondrial function | Cultured cells | Mouse | Kidney disease | Medical University of South Carolina | LC-MS |
| ST002787 | AN004534 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | LC-MS |
| ST002754 | AN004469 | Metabolomics analysis of maternal obesity model | Blood | Mouse | Fatty liver disease | University of Bonn | LC-MS |
| ST002747 | AN004457 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Human | CZ Biohub | LC-MS | |
| ST002747 | AN004457 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Rickettsia parkeri | CZ Biohub | LC-MS | |
| ST002569 | AN004233 | Lipidomic analysis in very-long chain acyl-CoA dehydrogenase null mice | Heart | Mouse | VLCAD deficiency | Montreal Heart Institute | LC-MS |
| ST002555 | AN004207 | Ethnicity-Specific Differences in Ovarian Cancer Metabolic Signatures | Cultured cells | Human | Cancer | University of Oklahoma Health Sciences Center | LC-MS |
| ST002522 | AN004156 | Lipidomics study on the effect of LBP protein on hepatic lipid composition in mice | Liver | Mouse | Oxidative stress | University of Science and Technology of China | LC-MS |
| ST002505 | AN004127 | A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) | Cultured cells | Human | Cancer | University of Science and Technology of China | LC-MS |
| ST002498 | AN004655 | Plasma Metabolomics Profiling of 580 Patients from the Weill Cornell Medicine Early Detection Research Network Prostate Cancer Cohort | Blood | Human | Cancer | Weill Cornell Medicine | LC-MS |
| ST002403 | AN003917 | Deep multi-omic profiling reveals extensive mitochondrial remodeling driven by glycemia in early diabetic kidney disease (Mitochondria) | Mitochondria | Rat | Kidney disease | Baker Heart and Diabetes Institute | LC-MS |
| ST002322 | AN003789 | Metabolomics study comparing SCAP KO and WT B cells | Cultured cells | Mouse | Indiana University School of Medicine | LC-MS | |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Blood | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Epididymal fat | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Liver | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Muscle | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Ventricles | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002155 | AN003530 | Longitudinal metabolomic stool dynamics in primary C. difficile infections | Feces | Human | Bacterial infection | Brigham and Women's Hospital | LC-MS |
| ST002150 | AN003520 | Sphingomyelin depletion inhibits CXCR4 dynamics and CXCL12-mediated directed cell migration in human T cells | HEK cells | Human | Universidad CEU San Pablo | LC-MS | |
| ST002149 | AN003519 | In vivo commensal control of Clostridioides difficile virulence | Cecum | Mouse | Brigham and Women's Hospital | LC-MS | |
| ST002090 | AN003414 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 2) | Feces | Mouse | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002089 | AN003411 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST002088 | AN003407 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST002019 | AN003289 | TIPs Metabolomics (blood) | Blood | Human | Vanderbilt University Medical Center | LC-MS | |
| ST002018 | AN003288 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) | Feces | Human | Vanderbilt University Medical Center | LC-MS | |
| ST002017 | AN003287 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Blood | Human | Vanderbilt University Medical Center | LC-MS | |
| ST001983 | AN003234 | Metabolomic Fingerprinting of Human High Grade Serous Ovarian Carcinoma Cell Lines | Ovarian cancer cells | Human | Cancer | University of Oklahoma Health Sciences Center | LC-MS |
| ST001942 | AN003184 | Lipidomics of esophageal adenocarcinoma | Esophagus | Human | Cancer | QIMR Berghofer Medical Research Institute | LC-MS |
| ST001940 | AN003155 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003156 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003157 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001940 | AN003158 | Cognitive Behavioral Therapy for Irritable Bowel Syndrome Induces Bidirectional Alterations in the Brain-Gut-Microbiome Axis Associated with Gastrointestinal Symptom Improvement | Feces | Human | Irritable bowel syndrome | University of California, Los Angeles | LC-MS |
| ST001935 | AN003147 | Metabolomic profiling of spontaneous macaque model for diabetes mellitus | Blood | Macaque monkey | Diabetes | Xiamen University | GC-MS |
| ST001935 | AN003147 | Metabolomic profiling of spontaneous macaque model for diabetes mellitus | Liver | Macaque monkey | Diabetes | Xiamen University | GC-MS |
| ST001919 | AN003118 | Exposure to environmental contaminants is associated with alterations in hepatic lipid metabolism in non-alcoholic fatty liver disease | Liver | Mouse | Fatty liver disease | Örebro University | LC-MS |
| ST001907 | AN003104 | Training-induced bioenergetic improvement in human skeletal muscle is associated with non-stoichiometric changes in the mitochondrial proteome without reorganisation of respiratory chain content | Muscle | Human | Baker Heart and Diabetes Institute | LC-MS | |
| ST001870 | AN003032 | Effects of GP130 Antagonism on Right Ventricular Metabolism in Monocrotaline Rats | Heart | Rat | University of Minnesota | LC-MS | |
| ST001869 | AN003031 | WNK463 Inhibition on Right Ventricular metabolomics | Heart | Rat | Hypertension | University of Minnesota | LC-MS |
| ST001835 | AN002977 | Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes | Blood | Human | Idaho Veterans Research and Education Foundation | LC-MS | |
| ST001827 | AN002963 | The pregnancy metabolome from a multi-ethnic pregnancy cohort | Blood | Human | Icahn School of Medicine at Mount Sinai | LC-MS | |
| ST001819 | AN002952 | EC and PVC from 14-15 month-old APOE3/3, APOE3/4 and APOE4/4 mice | Brain | Mouse | Alzheimers disease | Columbia University | LC-MS |
| ST001796 | AN002917 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib | Mesenteric lymph | Mouse | Diabetes | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST001795 | AN002915 | Changes in mesenteric lymph lipid profile of mice upon high-fat diet with and without Celecoxib (part I) | Mesenteric lymph | Mouse | Obesity | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST001775 | AN002882 | Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi | Blood | Mouse | Malaria | Stanford University | LC-MS |
| ST001749 | AN002849 | REACH Metabolomics Study | Blood | Human | Alzheimers disease | University of Wisconsin-Madison | LC-MS |
| ST001710 | AN002785 | Metabolic signatures of NAFLD - Lipidomics data (part 1 of 3) | Blood | Human | Fatty liver disease | Örebro University | LC-MS |
| ST001689 | AN002759 | Exposure to per- and polyfluoroalkyl substances associates with altered lipid profile of breast milk (Part 1) | Breast milk | Human | Environmental exposure | University of Turku | LC-MS |
| ST001686 | AN002753 | Exposure to per- and polyfluoroalkyl substances associates with altered lipid profile of breast milk (Part 3) | Blood | Human | Environmental exposure | University of Turku | LC-MS |
| ST001676 | AN002734 | Lipidomic analysis of CD4+ T-cell subsets (Th1,Th2,Th17 and iTreg cells) (part I) | T-cells | Human | University of Turku | LC-MS | |
| ST001639 | AN002682 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST001411 | AN002361 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Blood | Human | Obesity | University of Michigan | LC-MS |
| ST001405 | AN002347 | MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models | Cultured cells | Human | Ohio State University | LC-MS | |
| ST001404 | AN002346 | Ontogeny related changes in the pediatric liver metabolome (part-III) | Liver | Human | Moffitt Cancer Center | LC-MS | |
| ST001403 | AN002345 | Ontogeny related changes in the pediatric liver metabolome (part-II) | Liver | Human | Moffitt Cancer Center | LC-MS | |
| ST001336 | AN002226 | Effect of high-fat diet and bile acid treatment on serum and tissue lipidomes in mice | Blood | Mouse | QIMR Berghofer Medical Research Institute | LC-MS | |
| ST001323 | AN002199 | Effect of high-fat diet on serum lipidome in mice | Blood | Mouse | QIMR Berghofer Medical Research Institute | LC-MS | |
| ST001289 | AN002142 | Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS | |
| ST001288 | AN002141 | Subcellular organelle lipidomics in TLR-4-activated macrophages | Macrophages | Mouse | LIPID MAPS | LC-MS | |
| ST001286 | AN002136 | Lipid composition of isolated lipid droplets from the functional bovine corpus luteum | Ovaries | Cow | University of Nebraska Medical Center | LC-MS | |
| ST001275 | AN002116 | Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-II) | Cultured cells | Trypanosoma brucei | Sleeping sickness | Monash University | LC-MS |
| ST001253 | AN002080 | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Blood | Mouse | Diabetes | Indiana University School of Medicine | LC-MS |
| ST001251 | AN002077 | The effects of a training program encompassing cold exposure, breathing exercises, and meditation on plasma metabomics during experimental human endotoxemia | Blood | Human | Endotoxemia | Radboud University Medical Centre | LC-MS |
| ST001212 | AN002044 | Fish-oil supplementation in pregnancy, child metabolomics and asthma risk | Blood | Human | University of Copenhagen | LC-MS | |
| ST001158 | AN001916 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-II) | Feces | Mouse | Johns Hopkins University | LC-MS | |
| ST001157 | AN001915 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) | Blood | Mouse | Johns Hopkins University | LC-MS | |
| ST001073 | AN001755 | Lipid profiling of Wnt3a-induced optic nerve regeneration | Eye tissue | Mouse | Eye disease | University of Miami | LC-MS |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001019 | AN001667 | Lipidomic profiling of heart and plasma of mice following swim training versus pressure overload | Blood | Mouse | Baker Heart and Diabetes Institute | LC-MS | |
| ST001019 | AN001667 | Lipidomic profiling of heart and plasma of mice following swim training versus pressure overload | Heart | Mouse | Baker Heart and Diabetes Institute | LC-MS | |
| ST000930 | AN001524 | Define alterations in the gut metabolome of mice infected with C. difficile | Cecum | Mouse | North Carolina State University | LC-MS | |
| ST000917 | AN001501 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine | Urine | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000916 | AN001495 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma | Blood | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000915 | AN001489 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000899 | AN001463 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Blood | Human | Inflammatory bowel disease | Vanderbilt University Medical Center | LC-MS |
| ST000620 | AN000952 | Sphingolipid Analysis of hyper and normotensive DBA2J mice aqueous humor and trabecular meshwork | Eye tissue | Mouse | Eye disease | University of Miami | MS(Dir. Inf.) |
| ST000613 | AN000938 | Human TM Sphingolipid Analysis (part II) | Eye tissue | Human | Eye disease | University of Miami | MS(Dir. Inf.) |
| ST000612 | AN000937 | Sphingolipid Analysis of Human Aqueous Humor in Glaucomatous and Control eyes | Eye tissue | Human | Eye disease | University of Miami | MS(Dir. Inf.) |
| ST000452 | AN000708 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Serum raw data | Blood | Mouse | University of North Carolina at Chapel Hill | GC-MS | |
| ST000451 | AN000707 | The alpha-1A adrenergic receptor agonist A61603 reduces cardiac polyunsaturated fatty acid-Heart raw data | Muscle | Mouse | University of North Carolina at Chapel Hill | GC-MS | |
| ST000362 | AN000594 | Associations between 69 Sphingolipids and Emphysema, Chronic Bronchitis, Exacerbations, and FEV1/FVC | Blood | Human | COPD | National Jewish Health | LC-MS |
| ST000310 | AN000490 | TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) | Blood | Mouse | Lupus | University of Florida | LC-MS |
| ST000310 | AN000492 | TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) | Blood | Mouse | Lupus | University of Florida | LC-MS |
| ST000047 | AN000082 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
| ST000005 | AN000012 | Timecourse on RAW 264.7 cells treated with Kdo2-Lipid A and compactin | Macrophages | Mouse | LIPID MAPS | GC-MS/LC-MS |
